FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:507-509 February 17, 1994 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Turpie, A. PubMed Citation

To the Editor: In a recent paper (Aug. 19 issue), Turpie et al. report a beneficial effect of adding aspirin to warfarin treatment for heart-valve recipients¹. We question the interpretation of this study.

The risk of major embolism among patients who received both aspirin and warfarin was 1.6 percent per year, a figure higher than those from the literature for treatment with oral anticoagulants only. Bloomfield et al.² found a 12-year cumulative risk of 8.8 percent, which corresponds to an annual incidence of about 0.8 percent (and not, as stated by Turpie et al., of 2 to 3 percent, . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Kaplon, R. J., Cosgrove, D. M. III, Gillinov, A. M., Lytle, B. W., Blackstone, E. H., Smedira, N. G. (2000). Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival. Ann. Thorac. Surg. 70: 438-441 [Abstract] [Full Text]  
• Sturzenegger, M., Beer, J. H., Rihs, F. (1995). Monitoring Combined Antithrombotic Treatments in Patients With Prosthetic Heart Valves Using Transcranial Doppler and Coagulation Markers. Stroke 26: 63-69 [Abstract] [Full Text]